BiotechTube
Home/Senseera/Dr. Israa Sharkia
DI

Dr. Israa Sharkia

VP R&D

Senseera

Therapeutic Areas

HepatologyOncologyTransplantImmunologyMetabolic Disease

Senseera Pipeline

DrugIndicationPhase
Liver Transplant Rejection AssayAcute cellular rejectionClinical POC
MASH Biomarker PanelNon‑alcoholic steatohepatitisClinical POC
HCC Diagnostic TestHepatocellular carcinomaClinical POC

Leadership Team at Senseera

DR
Dr. Ronen Sadeh
CEO
PN
Prof. Nir Friedman
CSO
DJ
Dr. Jenia Gutin
CTO
DB
Daniella Beller
COO & Head of Business Development
View full Senseera profile